OrbiMed Advisors III Ltd
- SEC CIK
- 0001841537
No open-market purchases or sales filed in the past year.
Current role at each company
- TERN Terns Pharmaceuticals, Inc.Director, 10% Owneras of Jul 17, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists OrbiMed Advisors III Ltd as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2024 (view filing)8:48 PM ET | Jul 15-16 | 2 days | OrbiMed Advisors LLC and 4 othersDirector, 10% Owner | SSale | −56.2K | $10.00 | −$561.6K | −6.9%755.6K after | 6 lots10b5-1Duplicate filing |
| Dec 28, 2022 (view filing)5:57 PM ET | Dec 23 | 5 days | OrbiMed Advisors LLC and 4 othersDirector, 10% Owner | PPurchase | +137.9K | $7.25 | +$1.00M | +2.9%4.88M after | Duplicate filing |
| Aug 18, 2022 (view filing)5:00 PM ET | Aug 16 | 2 days | OrbiMed Advisors LLC and 4 othersDirector, 10% Owner | PPurchase | +3.69M | $2.42 | +$8.93M | New position762.4K after | 3 lotsDuplicate filing |
| Aug 18, 2022 (view filing)5:00 PM ET | Aug 16 | 2 days | OrbiMed Advisors LLC and 4 othersDirector, 10% Owner | PPurchase | +310.0K | – | – | –64.0K after | Derivative3 lotsDuplicate filing |